Skip to Main Content

Clinical Trials

NHLBI IPFnet: PANTHER-IPF: Prednisone, Azathioprine, N-Acetylcysteine:

A Study That Evaluates Responses in IPF

Fibrogen:

A Phase 2a, Open-Label, Single-Arm Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects with Idiopathic Pulmonary Fibrosis

Intermune: PIPF-0012:

An Open-Label Extension Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Who Complete the CAPACITY Studies

Fibrogen 3019-067:

Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients with Idiopathic Pulmonary Fibrosis

Gilead GS-US-322-0207:

RAINIER, A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis